FDA 483 - Biomat USA Inc - July 19, 2019

GCAM, Inc. in Pasco, WA, a plasmapheresis center, was inspected by the FDA. The inspection revealed a significant failure to obtain required donor contact information, specifically a postal address for 8-week post-donation contact. This indicates a lapse in donor eligibility screening procedures and standard operating procedures.